Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P. Nov 12, 2025 12:18PM
Tango Therapeutics raises $225 million in stock offering Oct 23, 2025 07:25AM
Tango Therapeutics Announces $225 Million Financing Oct 23, 2025 07:20AM
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P. Aug 13, 2025 05:01PM
Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P. Jun 13, 2025 05:25PM


Aug 10, 2021 09:00AM Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies